These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23898886)

  • 21. Experience with triple-drug therapy in a pharmacological erection program.
    Govier FE; McClure RD; Weissman RM; Gibbons RP; Pritchett TR; Kramer-Levien D
    J Urol; 1993 Dec; 150(6):1822-4. PubMed ID: 8230514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of erectile responses to vasoactive drugs by a variable amplitude oscillation device.
    Chun SS; Fenemore J; Heaton JP; Johnston B; Morales A
    Int J Impot Res; 1996 Dec; 8(4):221-5. PubMed ID: 8981171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maximisation of the erectile response in the investigation of impotence.
    Mills RD; Sethia KK
    Int J Impot Res; 1999 Feb; 11(1):29-32; discussion 33-4. PubMed ID: 10098951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetic impotence treated by intracavernosal injections: high treatment compliance and increasing dosage of vaso-active drugs.
    Perimenis P; Gyftopoulos K; Athanasopoulos A; Barbalias G
    Eur Urol; 2001 Oct; 40(4):398-402; discussion 403. PubMed ID: 11713393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of a visual analog scale to assess pain of injection with intracavernous injection therapy.
    Lane BR; Ausmundson SJ; Butler RS; Zippe CD; Jones JS; Lakin MM
    J Sex Med; 2005 May; 2(3):428-31. PubMed ID: 16422875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experience with intracavernosal tri-mixture for the management of neurogenic erectile dysfunction.
    Chao R; Clowers DE
    Arch Phys Med Rehabil; 1994 Mar; 75(3):276-8. PubMed ID: 8129578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of re-dosing of vasodilators on the intracavernosal pressure and on the penile rigidity.
    de Meyer JM; Thibo P
    Eur Urol; 1998; 33(3):293-6; discussion 296-7. PubMed ID: 9555555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sexual quality of life in women partnered with men using intracavernous alprostadil injections after radical prostatectomy.
    Yiou R; Ebrahiminia V; Mouracade P; Lingombet O; Abbou C
    J Sex Med; 2013 May; 10(5):1355-62. PubMed ID: 23444881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What is the current role of intracavernosal injection in management of erectile dysfunction?
    El-Sakka AI
    Int J Impot Res; 2016 May; 28(3):88-95. PubMed ID: 27076113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Current role of intracavernous therapy in the treatment of erectile dysfunction].
    Asuar Aydillo S
    Arch Esp Urol; 2002 Jun; 55(5):475-82. PubMed ID: 12174413
    [No Abstract]   [Full Text] [Related]  

  • 31. Relation between intracavernosal dose of prostaglandin Pge 1 and mean duration of erection in men with different underlying causes of erectile dysfunction.
    Bratus D; Hlebic G; Hajdinjak T
    Croat Med J; 2007 Feb; 48(1):76-80. PubMed ID: 17309142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracavernous injection in the treatment of erectile dysfunction after radical prostatectomy: an observational study.
    Claro Jde A; de Aboim JE; Maríngolo M; Andrade E; Aguiar W; Nogueira M; Nardozza Júnior A; Srougi M
    Sao Paulo Med J; 2001 Jul; 119(4):135-7. PubMed ID: 11500786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term intracavernous therapy responders can potentially switch to sildenafil citrate after radical prostatectomy.
    Raina R; Lakin MM; Agarwal A; Ausmundson S; Montague DK; Zippe CD
    Urology; 2004 Mar; 63(3):532-7; discussion 538. PubMed ID: 15028452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of an erectogenic pharmacotherapy regimen following radical prostatectomy improves recovery of spontaneous erectile function.
    Mulhall J; Land S; Parker M; Waters WB; Flanigan RC
    J Sex Med; 2005 Jul; 2(4):532-40; discussion 540-2. PubMed ID: 16422848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The female factor: predicting compliance with a post-prostatectomy erectile preservation program.
    Moskovic DJ; Mohamed O; Sathyamoorthy K; Miles BJ; Link RE; Lipshultz LI; Khera M
    J Sex Med; 2010 Nov; 7(11):3659-65. PubMed ID: 20819141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erectile dysfunction patients are more satisfied with penile prosthesis implantation compared with tadalafil and intracavernosal injection treatments.
    Kucuk EV; Tahra A; Bindayi A; Onol FF
    Andrology; 2016 Sep; 4(5):952-6. PubMed ID: 27368423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rehabilitation of the cavernous smooth muscle in patients with organic erectile dysfunction.
    Salem H; Mostafa T
    Andrologia; 2012 Apr; 44(2):125-9. PubMed ID: 21592173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pre- and Post-Injection Needle Pain in Patients Undergoing First Intracavernosal Injection.
    Baird B; Wajswol E; Ericson C; Anderson A; Broderick G
    J Sex Med; 2022 Apr; 19(4):590-593. PubMed ID: 35227620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repeated intracorporeal self-injection: effect on peak systolic velocity and cavernosal artery diameter.
    Awad H; El-Karaksy A; Mostafa T; Abbas M; Kamel II; Arafa M; Zeidan A
    Int J Impot Res; 2007; 19(5):505-8. PubMed ID: 17581595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracavernosal injection therapy with and without sexological counselling in men with erectile dysfunction.
    van der Windt F; Dohle GR; van der Tak J; Slob AK
    BJU Int; 2002 Jun; 89(9):901-4. PubMed ID: 12010236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.